Cas No.: | 1313498-08-6 |
Chemical Name: | 5-[(7S)-3-Tert-butyl-5H,6H,7H,8H-[1,2,4]triazolo[4,3-a]pyridin-7-yl]-3-(4-fluorophenyl)-1,2,4-oxadiazole |
Synonyms: | LSN2814617;5-[(7S)-3-tert-butyl-5H,6H,7H,8H-[1,2,4]triazolo[4,3-a]pyridin-7-yl]-3-(4-fluorophenyl)-1,2,4-oxadiazole;GTPL6395;BCP13851;BDBM50441231;BCP9000877;Q27081905;(7s)-3-t-butyl-7-[3-(4-fluoro-phenyl)-1,2,4-oxadiazol-5-yl]-5,6,7,8-tetrahydro[1,2,4]triazolo[4,3-a]pyridine |
SMILES: | FC1C=CC(=CC=1)C1=NOC([C@@H]2CC3=NN=C(C(C)(C)C)N3CC2)=N1 |
Formula: | C18H20FN5O |
M.Wt: | 341.382706642151 |
Purity: | >98% |
Sotrage: | 2 years -20°C Powder, 2 weeks 4°C in DMSO, 6 months -80°C in DMSO |
Description: | LSN2814617 is a neurotoxic positive allosteric modulator. For the detailed information of LSN2814617, the solubility of LSN2814617 in water, the solubility of LSN2814617 in DMSO, the solubility of LSN2814617 in PBS buffer, the animal experiment (test) of LSN2814617, the cell expriment (test) of LSN2814617, the in vivo, in vitro and clinical trial test of LSN2814617, the EC50, IC50,and affinity,of LSN2814617, Please contact DC Chemicals. |